Skip to content
A.K. Pharma
Home
Products
About
Blogs
Contact
Home
Products
About
Blogs
Contact
A.K. Pharma
PIK3CA mutated breast cancer
Pivikto® (Alpelisib)
Alpelisib 150mg, 200mg, 250mg+50mg Film-Coated Tablets — PI3Kα-Selective Inhibitor for HR-Positive HER2-Negative PIK3CA-Mutated Advanced or Metastatic Breast Cancer in Combination With Fulvestrant
Request Quote
Menu
Home
Products
About
Blogs
Contact
Quote Request Form
Name
Email
Phone
Message
Ask for quote!
Quote Request Form
Name
Email
Phone
Message
Let's get started!
